Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- HEALTHCARE FORUM
December 12, 2005
- BUSINESS NEWS IN BRIEF
December 12, 2005
- Councilor Calls For Medical, Nursing Fees that Promote Home Care
December 12, 2005
- Korosho Proposes Simplification of Dispensing Fees
December 12, 2005
- 4 Industry Groups Present Their Views at Chuikyo
December 12, 2005
- Chuikyo Makes No Recommendation on Medical Fee Revision
December 12, 2005
- Decision on Pricing of Long-listed Products in Limbo Until Year-end
December 12, 2005
- Korosho to Deal with NHI Drug Prices before Medical Fees: Mr Kawasaki
December 12, 2005
- Healthcare Reform Framework Announced
December 12, 2005
- UCB Aims at Innovation for Specialists
December 12, 2005
- SELF-MEDICATION NEWS IN BRIEF
December 12, 2005
- Discussions on OTC Drug Marketing to Conclude Soon
December 12, 2005
- Japan Lags Behind in Use of Insulin Pump for Type 1 Diabetics
December 12, 2005
- Breast Cancer Screening Needed in Women in Their 40s: Prof. Ohuchi
December 12, 2005
- SURVEY 2 articles
December 12, 2005
- Saitama Medical School Creates Wound Healing & Regenerative Medicine Center
December 12, 2005
- Dr Takenaka Talks on Pharma Industry 10 Years Back and 10 Ahead
December 12, 2005
- MEDICAL DEVICE NEWS IN BRIE
December 12, 2005
- 23 TSE-listed Drug Firms' Sales Up 2.7% to \2,764,792 Mil.
December 12, 2005
- R&D NEWS IN BRIEF
December 12, 2005
ページ
Japan will overhaul its R&D tax credit regime in its FY2026 reform, introducing a new strategic category alongside existing frameworks.…
Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…